Fuda Cancer Hospital
Fuda Cancer Hospital
China, Cantón
Ewing's sarcoma treatment cost in China typically runs from $75,000 to $140,000 for complex multimodal care. Essential diagnostics like a complete blood count range from $100 to $100, while primary radiation therapy for sarcomas costs $10,500 to $21,700. Total expenses depend on the treatment stage, surgical technology, and clinic tier. Patients often save 50% to 70% compared to the United States. Top treatment hubs include Guangzhou, Shanghai, and Beijing.
Typical Ewing's Sarcoma Treatment Costs in China
Bookimed Expert Insight: Patients with advanced or late-stage Ewing's sarcoma benefit from multidisciplinary care at JCI-accredited centers. Fuda Cancer Hospital in Guangzhou specializes in minimally invasive alternatives to standard chemotherapy, utilizing technologies like NanoKnife and cryosurgery. For those requiring precision radiation, expert-led teams provide IMRT and VMAT protocols. Choosing centers with high international patient volumes ensures access to coordinated, multi-step regimens at competitive rates.
| China | España | Turquía | |
| Tratamiento complejo del sarcoma de Ewing | de $75,000 | de $35,000 | de $30,000 |
| Resección ósea | de $9,500 | de $20,000 | de $8,000 |
| Radioterapia para sarcomas | de $10,500 | de $8,000 | de $3,250 |
| Radioterapia para el cáncer colorrectal | de $11,500 | de $10,000 | de $7,000 |
| Quimioterapia para el cáncer de mama | de $14,800 | de $3,500 | de $1,200 |
Bookimed no añade cargos extra a los precios de los tratamientos de Sarcoma de Ewing. Las tarifas proceden de las listas de precios oficiales de las clínicas. Pagará directamente en la clínica por su tratamiento a su llegada al país.
Bookimed está comprometido con su seguridad. Solo trabajamos con las clínicas que mantienen altos estándares internacionales en el tratamiento de Sarcoma de Ewing y cuentan con las licencias necesarias para atender a pacientes internacionales en todo el mundo.
Bookimed ofrece asistencia experta gratuita. Un coordinador médico personal le apoya antes, durante y después de su tratamiento, resolviendo cualquier problema. Nunca estará solo en su viaje médico de tratamiento de Sarcoma de Ewing.
El profesor Shixin Liu, MD, PhD, es el líder de la disciplina del Centro de Oncología. Fue presidente del Hospital Oncológico Provincial de Jilin y director del Instituto de Investigación en Prevención y Tratamiento del Cáncer. Es profesor de nivel II y tutor de doctorado. Ha recibido la Asignación Especial del Gobierno del Consejo de Estado, el 4.º premio Médico Nacional Famoso (Contribución Sobresaliente) y la distinción Modelo de Ética Médica.
Se especializa en el diagnóstico y tratamiento integrales de tumores malignos. Su enfoque es la radioterapia de precisión para cánceres torácicos y abdominales. Domina IMRT, VMAT y SBRT para cáncer de pulmón, esófago, mama y recto.
Sus cargos de liderazgo incluyen la vicepresidencia de Oncología Radioterápica de la CMA, de Radioterapia de la CACA y de Terapia de Partículas de la CACA. Integra el Comité Permanente de la CSCO y es vicepresidente del Comité de Expertos en Oncología Radioterápica de la CSCO. Es vicepresidente de Oncología Radioterápica de la CPAM y miembro del Comité Permanente de la CSMEA. Preside la sección de Oncología Radioterápica de la Asociación Médica de Jilin. Forma parte de los consejos editoriales del Chinese Journal of Radiation Oncology y del Practical Journal of Cancer.
Ewing sarcoma treatment in China follows a multimodal protocol of systemic chemotherapy, surgical resection, and radiation therapy. Chinese centers utilize international standards from the Chinese Society of Clinical Oncology. Specific regimens include alternating VDC and IE chemotherapy cycles to target the primary tumor and micrometastases.
Bookimed Expert Insight: While major centers follow international guidelines, JCI-accredited facilities like Fuda Cancer Hospital offer unique minimally invasive alternatives. They utilize technologies like NanoKnife and cryosurgery for advanced cases. This allows for localized tumor destruction in patients who cannot tolerate traditional aggressive surgery or high-dose chemotherapy cycles.
Patient Consensus: Patients emphasize traveling to high-volume metropolitan centers for accurate pathology and molecular testing. They note that starting neoadjuvant chemotherapy quickly is vital given the aggressive nature of this sarcoma.
China offers advanced local therapies for sarcomas. These include cryosurgery, NanoKnife, and carbon ion radiotherapy. Specialized centers utilize High-Intensity Focused Ultrasound (HIFU) for non-invasive treatment. These techniques target complex tumors while preserving healthy tissue and critical structures near the tumor site.
Bookimed Expert Insight: Fuda Cancer Hospital stands out for managing late-stage cases using unique combinations. They integrate cryosurgery with vascular interventional therapy for difficult tumors. This approach is particularly valuable for patients from over 100 countries. It serves those whose tumors are considered unresectable in other regions.
Patient Consensus: Patients value the availability of proton therapy for protecting the spine and pelvis. They emphasize that the best results come from teams combining orthopedic oncology with reconstruction specialists.
Top hospitals in China for Ewing's sarcoma include elite institutions like Fuda Cancer Hospital and Beijing Jishuitan Hospital. Specialized centers focus on limb-sparing operations and advanced radiation. These facilities maintain Joint Commission International (JCI) accreditation. They utilize multidisciplinary teams for coordinated chemotherapy, surgery, and radiotherapy protocols.
Bookimed Expert Insight: Coordination between pediatric and orthopedic departments is the strongest quality signal in Chinese centers. Fuda Cancer Hospital manages over 30,000 international patients by offering over 10 types of minimally invasive therapies. This specialized focus on non-systemic treatments provides options for cases where traditional heavy chemotherapy is difficult.
Patient Consensus: Patients emphasize finding a dedicated orthopedic oncology unit rather than a general hospital. They warn that initial biopsy planning is critical to ensuring limb-sparing surgery remains possible later.
Verify Chinese medical quality by confirming a facility Tier 3A (Sanjia) status. This government ranking represents the highest level of safety and technology. Look for Joint Commission International (JCI) accreditation and doctors with Senior Physician (Zhuren Yishi) titles for complex sarcoma care.
Bookimed Expert Insight: Look beyond general cancer volume to find specialized leaders. Professor Dr. Liu Shi Xin at Xiamen Humanity Hospital holds elite State Council honors. This designation is rarer and more significant than standard hospital rankings for complex Ewing's sarcoma cases.
Patient Consensus: Patients emphasize asking for the team’s specific experience with primary bone sarcomas. They recommend getting a written multidisciplinary plan including chemotherapy and radiation before traveling.
Chinese oncology centers often integrate Traditional Chinese Medicine (TCM) with Western protocols. Integrated therapies focus on managing side effects. JCI-accredited facilities like Fuda Cancer Hospital use complementary techniques. These support recovery during bone resection and chemotherapy. Always coordinate with your specialist oncology team first.
Bookimed Expert Insight: Top Chinese oncology centers often focus on biological synergy. Fuda Cancer Hospital uses minimally invasive therapies like NanoKnife alongside TCM. This combination aims to manage advanced stages where standard chemo is difficult. Our data shows patients choose China specifically for this integrative multi-technology approach.
Patient Consensus: Patients emphasize using TCM only for comfort and appetite during treatment. They warn that herbs should never replace surgery or radiation for aggressive sarcomas.